QR kód

Tumour Versus Germline <i>BRCA</i> Testing in Ovarian Cancer: A Single-Site Institution Experience in the United Kingdom

The aim of this audit was to evaluate the usefulness and serviceability of testing for pathogenic mutations in <i>BRCA1</i> or <i>BRCA2</i> (<i>BRCA1/2</i>) genes in ovarian cancer (OC) patients. One hundred and thirty-five patients with more common histological sub-types of OC were retrospectively...

Celý popis

Uloženo v:
Hlavní autoři: Iolia Akaev, Siavash Rahimi, Olubukola Onifade, Francis John Edward Gardner, David Castells-Rufas, Eleanor Jones, Shyamika Acharige, Chit Cheng Yeoh
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2021-03-01
Edice:Diagnostics
Témata:
<i>BRCA1</i>
<i>BRCA2</i>
tumour
somatic
carcinoma
ovarian
On-line přístup:https://www.mdpi.com/2075-4418/11/3/547
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky